Daron G. Ferris

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Suzanne M. Garland, Mauricio Hernández‐Ávila, Cosette M. Wheeler et al. · New England Journal of Medicine · 2007 · 1.9K citations

Medicine, Infectious Diseases, Preventive Medicine +17

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2004 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

Darron R. Brown, Susanne K. Kjær, Kristján Sigurðsson et al. · The Journal of Infectious Diseases · 2009 · 627 citations · Full text

Medicine, Oncology, Pathology +17

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Elmar A. Joura, Sepp Leodolter, Mauricio Hernández‐Ávila et al. · The Lancet · 2007 · 580 citations

Medicine, Gynecology, Oncology +17

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Nubia Muñóz, Susanne K. Kjær, Kristján Sigurðsson et al. · JNCI Journal of the National Cancer Institute · 2010 · 564 citations · Full text

Medicine, Gynecology, Infectious Diseases +16